During the past decade, Shandong Provincial Hospital conducted 99 clinical trials. In the 10-year time frame, 99 clinical trials started and 6 clinical trials were completed, i.e. on average, 6.1% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 3 clinical trials were completed. i.e. 5.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shandong Provincial Hospital" #1 sponsor was "Shandong Provincial Hospital" with 20 trials, followed by "Beijing InnoCare Pharma Tech Co., Ltd." with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Lifetech Scientific (Shenzhen) Co., Ltd." with 3 trials sponsored and "Nanfang Hospital of Southern Medical University" with 3 trials sponsored. Other sponsors include 84 different institutions and companies that sponsored additional 76 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shandong Provincial Hospital" #1 collaborator was "Shandong Provincial Hospital" with 16 trials as a collaborator, "Beijing 302 Hospital" with 4 trials as a collaborator, "Beijing Friendship Hospital" with 4 trials as a collaborator, "Beijing YouAn Hospital" with 4 trials as a collaborator and "West China Hospital" with 4 trials as a collaborator. Other collaborators include 255 different institutions and companies that were collaborators in the rest 206 trials.

According to Clinical.Site data, the most researched conditions in "Shandong Provincial Hospital" are "Alzheimer Disease" (2 trials), "Anemia" (2 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Colorectal Cancer" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Shandong Provincial Hospital" in a lesser frequency.

Most popular intervention types in "Shandong Provincial Hospital" are "Drug" (67 trials), "Device" (14 trials), "Other" (13 trials), "Procedure" (12 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "ICP-022" (3 trials), "placebo" (3 trials), "Cyclophosphamide (CTX)" (2 trials) and "Elranatamab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Shandong Provincial Hospital" are 115 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 55 active trials in "Shandong Provincial Hospital". 3 are not yet recruiting, 39 are recruiting, 10 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 33 completed trials in Shandong Provincial Hospital, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Shandong Provincial Hospital, 4 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 20 trials, and there were also 22 trials that are defined as “Not Applicable".